<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02797860</url>
  </required_header>
  <id_info>
    <org_study_id>KangnamSHH</org_study_id>
    <nct_id>NCT02797860</nct_id>
  </id_info>
  <brief_title>Comparison of Onset and Duration of Rocuronium Between 2nd Trimester Pregnant and Non-pregnant Women</brief_title>
  <official_title>Comparison of Onset and Duration of Rocuronium Induced Neuromuscular Block Between 2nd Trimester Pregnant and Non-pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Kangnam Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Kangnam Sacred Heart Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregnancy is associated with major changes of the body's physiological status and
      composition.

      These changes may modify the pharmacologic and/or pharmacokinetic profile of some drugs.
      Pharmacodynamic and pharmacokinetic changes in the 1st trimester during pregnancy are
      attributed to the following factors; Increase in plasma volume, heart rate and cardiac
      output; decrease in blood pressure due to decrease of systemic resistance and relative
      decrease of hepatic circulation and the aggravation of hepatic dysfunction. These changes
      intensify as pregnancy progresses into the 3rd trimester and take their effect on the onset
      time and duration of muscle relaxants.

      Rocuronium and the steroidal non-depolarizing muscle relaxant like vecuronium is mostly
      excreted with bile by hepatic metabolism and classified as the FDA pregnancy category B, and
      is widely used in general anesthesia of pregnant women. Previous studies reported onset time
      of rocuronium is affected by cardiac output, blood circulation time of the whole body, and
      muscle perfusion. Accordingly, many researches were conducted under the assumption of onset
      time and duration being affected by physiologic changes during pregnancy. For example, in the
      research where vecuronium was used as muscle relaxant for pregnant woman undergoing C-sec,
      onset of vecuronium was significantly shorter than that of the control group and duration was
      longer. In a study investigating rocuronium used for patients right after delivery, onset
      time was shorter and duration was longer than that of the control group.

      However, previous research mostly focused on the 3rd trimester, while there have been only a
      few studies of onset time and duration of rocuronium in non-obstetric surgery such as the
      transabdominal cervicoisthmic cerclage (TCIC) or Mcdonald surgery which are performed under
      general anesthesia during 2nd trimester. In this research, onset time and duration of
      rocuronium, which is widely used for general anesthesia in 2nd trimester pregnant females,
      will be compared with those of patients in the control group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>onset time of rocuronium</measure>
    <time_frame>until T1 of Train of Four watch is suppressed to 0%,assessed up to 5 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of rocuronium</measure>
    <time_frame>until T1 of Train of Four watch is recovered to 25%,assessed up to 1 hour</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>transabdominal cervicoisthmic cerclage</arm_group_label>
    <description>Second Stage of Labor pregnant women who are scheduled for transabdominal cervicoisthmic cerclage due to incompetent internal os of cervix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>women of childbearing age between 20 and 45</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>comparison of onset time and duration of rocuronium using Train of Four watch</description>
    <arm_group_label>transabdominal cervicoisthmic cerclage</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for Transabdominal cervicoisthmic cerclage under general anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for Transabdominal cervicoisthmic cerclage under general anesthesia
             or patients scheduled for elective open abdominal surgery.

          -  The American Society of Anesthesiologists physical status class one or two

          -  female between 20 and 45

        Exclusion Criteria:

          -  Patients with liver disease

          -  Patients with kidney disease

          -  Patients with Diabetes mellitus or heart disease

          -  Patients with asthma or Bronchial hypersensitivity

          -  Patients with a drug allergy

          -  Patients BMI under 18.5 or over 27
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Mi Choi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hallym University Kangnam Sacred Heart Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eun Mi Choi, MD</last_name>
    <phone>821090576639</phone>
    <email>emchoi96@hallym.or.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kangnam sacred heart hospital</name>
      <address>
        <city>Seoul</city>
        <state>Yeongdeungpo-gu</state>
        <zip>KS013</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Mi Choi, MD</last_name>
      <phone>821090576639</phone>
      <email>Emchoi96@hallym.or.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989 Apr;256(4 Pt 2):H1060-5.</citation>
    <PMID>2705548</PMID>
  </results_reference>
  <results_reference>
    <citation>Capeless EL, Clapp JF. When do cardiovascular parameters return to their preconception values? Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):883-6.</citation>
    <PMID>1951547</PMID>
  </results_reference>
  <results_reference>
    <citation>Greiss FC Jr, Anderson SG. Effect of ovarian hormones on the uterine vascular bed. Am J Obstet Gynecol. 1970 Jul 15;107(6):829-36.</citation>
    <PMID>5429013</PMID>
  </results_reference>
  <results_reference>
    <citation>Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, Schrier RW. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998 Dec;54(6):2056-63. Erratum in: Kidney Int 1999 Mar;55(3):1185.</citation>
    <PMID>9853271</PMID>
  </results_reference>
  <results_reference>
    <citation>Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol. 2001 May;97(5 Pt 1):669-72.</citation>
    <PMID>11339913</PMID>
  </results_reference>
  <results_reference>
    <citation>Van Thiel DH, Gavaler JS. Pregnancy-associated sex steroids and their effects on the liver. Semin Liver Dis. 1987 Feb;7(1):1-7.</citation>
    <PMID>3589711</PMID>
  </results_reference>
  <results_reference>
    <citation>Esbjörner E, Järnerot G, Sandström B, Ostling G. Serum albumin reserve for bilirubin binding during pregnancy in healthy women. Obstet Gynecol. 1989 Jan;73(1):93-6.</citation>
    <PMID>2909046</PMID>
  </results_reference>
  <results_reference>
    <citation>Wierda JM, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth. 1991 May;38(4 Pt 1):430-5.</citation>
    <PMID>1829656</PMID>
  </results_reference>
  <results_reference>
    <citation>Muñoz HR, González AG, Dagnino JA, González JA, Pérez AE. The effect of ephedrine on the onset time of rocuronium. Anesth Analg. 1997 Aug;85(2):437-40.</citation>
    <PMID>9249127</PMID>
  </results_reference>
  <results_reference>
    <citation>Szmuk P, Ezri T, Chelly JE, Katz J. The onset time of rocuronium is slowed by esmolol and accelerated by ephedrine. Anesth Analg. 2000 May;90(5):1217-9. Erratum in: Anesth Analg 2000 Oct;91(4):833.</citation>
    <PMID>10781483</PMID>
  </results_reference>
  <results_reference>
    <citation>Hans P, Brichant JF, Hubert B, Dewandre PY, Lamy M. Influence of induction of anaesthesia on intubating conditions one minute after rocuronium administration: comparison of ketamine and thiopentone. Anaesthesia. 1999 Mar;54(3):276-9.</citation>
    <PMID>10364866</PMID>
  </results_reference>
  <results_reference>
    <citation>Baraka A, Jabbour S, Tabboush Z, Sibai A, Bijjani A, Karam K. Onset of vecuronium neuromuscular block is more rapid in patients undergoing caesarean section. Can J Anaesth. 1992 Feb;39(2):135-8.</citation>
    <PMID>1347489</PMID>
  </results_reference>
  <results_reference>
    <citation>Camp CE, Tessem J, Adenwala J, Joyce TH 3rd. Vecuronium and prolonged neuromuscular blockade in postpartum patients. Anesthesiology. 1987 Dec;67(6):1006-8.</citation>
    <PMID>2891326</PMID>
  </results_reference>
  <results_reference>
    <citation>Sakurai Y, Uchida M, Aiba J, Mimura F, Yamaguchi M, Kakumoto M. [Effects of pregnancy on the onset time of rocuronium]. Masui. 2014 Mar;63(3):324-7. Japanese.</citation>
    <PMID>24724444</PMID>
  </results_reference>
  <results_reference>
    <citation>Pühringer FK, Sparr HJ, Mitterschiffthaler G, Agoston S, Benzer A. Extended duration of action of rocuronium in postpartum patients. Anesth Analg. 1997 Feb;84(2):352-4.</citation>
    <PMID>9024027</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2016</study_first_submitted>
  <study_first_submitted_qc>June 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2016</study_first_posted>
  <last_update_submitted>August 9, 2017</last_update_submitted>
  <last_update_submitted_qc>August 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hallym University Kangnam Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Choi Eun MI</investigator_full_name>
    <investigator_title>Hallym University Kangnam Sacred Heart Hospital</investigator_title>
  </responsible_party>
  <keyword>Transabdominal cervicoisthmic cerclage</keyword>
  <keyword>Rocuronium</keyword>
  <keyword>Pregnant Women</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

